Snowball logo
logo
1099

Sinopharm Group Co. Ltd

HK$15.34-HK$0.06ย  (0.39%)
Estimate
P/E
4.6
EPS
3.3
Beta
0.456
Growth
Revenue, YoY
-11.93%
Net income, YoY
-15.65%
Forecast
P/E (FWD)
6.2
EPS (FWD)
2.481
Dividends
Dividend yield
5.15%
Annual payout
HK$0.79
Next ex. div date
June 23, 27
Payout
49.3%
Div.growth, 5y
2.53%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
1099
ISIN
CNE100000FN7
Country
China
Sector (GICS)
Healthcare
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. Sinopharm Group Co. Ltd. was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Frequently asked questions

What sector does Sinopharm Group Co. Ltd (1099) operate in?

Sinopharm Group Co. Ltd belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is Sinopharm Group Co. Ltd (1099) current stock price?

As of the latest data, Sinopharm Group Co. Ltd stock price is HK$15.34, with a previous close of HK$15.40. Sinopharm Group Co. Ltd lost -HK$0.06 in the last trading session, representing a -0.39% loss.

What is Sinopharm Group Co. Ltd (1099) current market capitalization?

Sinopharm Group Co. Ltd market cap is approximately 20.58 billion.

What is Sinopharm Group Co. Ltd (1099) Earnings Per Share (EPS)?

The trailing EPS is HK$3.30, and the forward EPS is HK$2.48.

What is Sinopharm Group Co. Ltd (1099) Price-to-Earnings (P/E) ratio?

Sinopharm Group Co. Ltd current P/E ratio is 4.65, with a forward P/E of 6.18.

What is Sinopharm Group Co. Ltd (1099) EBITDA?

Sinopharm Group Co. Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 10.16 billion.

Does Sinopharm Group Co. Ltd (1099) pay dividends?

Yes. Sinopharm Group Co. Ltd pays annual dividends with an annualized yield of 5.15% and an estimated annual payout of HK$0.79 per share.

When is the next ex-dividend date for Sinopharm Group Co. Ltd (1099)?

The next ex-dividend date is scheduled for June 23, 2027.

When is Sinopharm Group Co. Ltd (1099) next earnings report?

Sinopharm Group Co. Ltd is expected to release its next earnings report on September 30, 2026.

What is Sinopharm Group Co. Ltd (1099) beta (volatility) score?

Sinopharm Group Co. Ltd has a beta of 0.456, indicating lower volatility than the overall market.